Article: ISPE Pharma 4.0™ SIG and its working groups

By Christian Wölbeling and the ISPE Pharma 4.0™ Special Interest Group Working Group Leads

The ISPE Pharma 4.0™ Special Interest Group (SIG) launched in 2015 to provide a road map for new challenges of digitalization, Industry 4.0, and the smart factory. The SIG addresses how pharmaceutical industry stakeholders, including regulatory authorities, can achieve benefits from Pharma 4.0™ initiatives.